The UK JCVI committee recently announced that vaccines would not be offered to all 12-17 year olds, as the potential risks were not outweighed by the benefits. Here, we offer a quantitative risk-benefit analysis of vaccines among 12-17 year olds in England, showing that the benefits of vaccination greatly outweigh risks among12-17 year olds in England in the current context.
This Preprint paper has been covered by The Guardian, Daily Mail and iNews this week.
UCL Queen Square Institute of Neurology achieves Gold in UCL Sustainability awards 2025
We're delighted to announce recognition of UCL Queen Square Institute of Neurology's commitment to sustainability at UCL’s Awards ceremony, taking home all Gold awards.
10 Jul 2025
Change the PATTERN: Addressing Unacceptable Behaviours in Academia
The PATTERN campaign is a collaborative initiative by UCL Queen Square Institute of Neurology and Koç University
08 Jul 2025
Global Business School for Health on the NHS 10 Year Plan for England
Professor Nora Colton, Director of the Global Business School for Health, responds to the recently published NHS 10 Year Plan for England
08 Jul 2025